14 Days Historical Data
| Date | Opening price | Closing price | Minimum price | Maximum price |
| 2022-03-30 | Open: 185.990 | Close: 174.920 | Low: 174.040 | High: 185.990 |
| 2022-03-29 | Open: 174.400 | Close: 180.640 | Low: 172.740 | High: 181.230 |
| 2022-03-28 | Open: 170.830 | Close: 173.080 | Low: 167.140 | High: 173.080 |
| 2022-03-25 | Open: 171.750 | Close: 165.830 | Low: 164.330 | High: 171.750 |
Full Answer
Will Moderna stock price go up or fall?
The Moderna stock price is 271.850 USD today. Will Moderna stock price grow / rise / go up? Yes. The MRNA stock price can go up from 271.850 USD to 379.147 USD in one year. Is it profitable to invest in Moderna stock? Yes. The long-term earning potential is + 39.47 % in one year. Will MRNA stock price fall / drop? No. See above .
What is the upside for Moderna's stock?
Their forecasts range from $85.00 to $395.00. On average, they anticipate Moderna's stock price to reach $242.88 in the next year. This suggests a possible upside of 47.1% from the stock's current price. View analysts' price targets for Moderna or view top-rated stocks among Wall Street analysts.
Is Moderna Inc (mRNA) a good long-term investment?
According to our live Forecast System, Moderna Inc stock is a very good long-term (1-year) investment*. "MRNA" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "MRNA" projections.
What is Moderna's (multi) stock price potential for next year?
Their forecasts range from $85.00 to $395.00. On average, they anticipate Moderna's stock price to reach $242.88 in the next year. This suggests a possible upside of 47.1% from the stock's current price.
"Should I invest in Moderna stock?" "Should I trade "MRNA" stock today?"
According to our live Forecast System, Moderna Inc stock is an awesome long-term (1-year) investme...
What is the Moderna stock price / share price today?
The Moderna stock price is 165.400 USD today.
Will Moderna stock price grow / rise / go up?
Yes. The MRNA stock price can go up from 165.400 USD to 258.067 USD...
Is it profitable to invest in Moderna stock?
Yes. The long-term earning potential is + 56.03 % in one year.
Will MRNA stock price fall / drop?
No. See above .
What will Moderna stock price be worth in five years (2027)?
The MRNA ("MRNA" ) future stock price will be 650.780 USD .
Will MRNA stock price crash?
According to our analysis, this will not happen.
Will Moderna stock price hit 1 000 USD price in a year?
Not within a year. See above .
Will Moderna stock price hit 2 000 USD price in a year?
Not within a year. See above .
Should I buy or sell Moderna stock right now?
14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Moderna in the last twelve months. There are currently...
What is Moderna's stock price forecast for 2022?
14 analysts have issued 1-year price objectives for Moderna's shares. Their forecasts range from $70.00 to $395.00. On average, they anticipate Mod...
How has Moderna's stock performed in 2022?
Moderna's stock was trading at $253.98 at the beginning of 2022. Since then, MRNA stock has decreased by 49.9% and is now trading at $127.12. View...
When is Moderna's next earnings date?
Moderna is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Moderna .
How were Moderna's earnings last quarter?
Moderna, Inc. (NASDAQ:MRNA) released its quarterly earnings results on Wednesday, May, 4th. The company reported $8.58 earnings per share for the q...
Who are Moderna's key executives?
Moderna's management team includes the following people: Dr. Noubar B. Afeyan Ph.D. , Co-Founder, Independent Non Exec. Chairman & Member of Tech...
What is Stéphane Bancel's approval rating as Moderna's CEO?
57 employees have rated Moderna CEO Stéphane Bancel on Glassdoor.com . Stéphane Bancel has an approval rating of 92% among Moderna's employees. Th...
Who are some of Moderna's key competitors?
Some companies that are related to Moderna include Amgen (AMGN) , Gilead Sciences (GILD) , BioNTech (BNTX) , Biogen (BIIB) , Seagen (SGEN) ,...
What other stocks do shareholders of Moderna own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Moderna investors own include NVIDIA (NVDA) , Tesla (TSLA...
What is the ticker symbol for Moderna?
Moderna trades on the NASDAQ under the ticker symbol "MRNA."
Where is Moderna located?
Moderna's mailing address is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. The company can be reached via phone at (617) 714-6500 or via email at [email protected].
What is the P/E ratio of Moderna?
The P/E ratio of Moderna is 16.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.19.
What does "hold" mean in Moderna?
A hold rating indicates that analysts believe investors should maintain any existing positions they have in MRNA, but not buy additional shares or sell existing shares. View analyst ratings for Moderna or view top-rated stocks.
Is Moderna a hold?
Wall Street analysts have given Moderna a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Moderna wasn't one of them.
Does Moderna pay dividends?
Moderna does not currently pay a dividend.
The stock needs to move even lower
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights
Key Points
Moderna's current valuation would be reasonable if the demand remains steady for its COVID-19 vaccine.
Is there a price discontinuity in 2020?
2020 has created many pricing discontinuities that can offer attractive trading opportunities. For example, you’ll be surprised how counter-intuitive the stock valuation is for Pfizer vs Merck.
Will Moderna be in 2022?
We expect the Covid-19 shot to remain the primary driver of Moderna's performance in 2022 as well. The global inoculation drive is still in the early stages, with the Bloomberg Vaccine Tracker estimating that vaccine doses have been administered to fully vaccinate just about 10% of the world’s population.
Is Moderna going to be profitable in 2021?
Moderna (NASDAQ: MRNA) is poised for a solid 2021 as it ramps up sales of its much sought-after Covid-19 vaccine. The company is on track to deliver between 800 million to 1 billion doses of the shot this year and based on its advance purchase agreements, sales for the year could top $19 billion, up from less than $1 billion in 2019. The vaccine is also turning out to be hugely profitable for Moderna, which recorded an incredible 70% net profit margin over Q1 2021. That said, with the worst of the pandemic likely to be behind us this year, what could 2022 have in store for Moderna?
Is Moderna a phase 3 company?
Moderna (MRNA) , a clinical-stage biotech company , is carrying out phase 3 trials of its Covid-19 vaccine, completing enrollment of 30,000 participants. The company is likely to have data on whether its vaccine works or not by this month, and has noted that it would seek emergency approval from the FDA if the vaccine is at least 70% effective. The stock is up 253% this year.
Is Moderna in phase 2?
Moderna has a large development pipeline that includes another nine vaccines and 13 therapeutics in areas including immuno-oncology and rare diseases. Four of the company's developments, including its CMV vaccine and personalized cancer vaccine, are in the phase 2 trials and any positive data surrounding these developments could also help the stock. ( ( Moderna Q1 Earnings Presentation )) With Moderna poised to generate big profits from its Covid-19 shot (as much as $10 billion this year), it will have the resources to bolster its pipeline further in the coming years.
Is there a price discontinuity in 2020?
2020 has created many pricing discontinuities that can offer attractive trading opportunities. For example, you’ll be surprised how counter-intuitive the stock valuation is for Pfizer vs Merck.
Is Moderna a phase 3 company?
Moderna (MRNA) , a clinical-s tage biotech company, is carrying out phase 3 trials of its Covid-19 vaccine, completing enrollment of 30,000 participants. The company is likely to have data on whether its vaccine works or not by this month, and has noted that it would seek emergency approval from the FDA if the vaccine is at least 70% effective. The stock is up 253% this year.
Is Moderna going to be profitable in 2021?
Moderna (NASDAQ: MRNA) is poised for a solid 2021 as it ramps up sales of its much sought-after Covid-19 vaccine. The company is on track to deliver between 800 million to 1 billion doses of the shot this year and based on its advance purchase agreements, sales for the year could top $19 billion, up from less than $1 billion in 2019. The vaccine is also turning out to be hugely profitable for Moderna, which recorded an incredible 70% net profit margin over Q1 2021. That said, with the worst of the pandemic likely to be behind us this year, what could 2022 have in store for Moderna?
When will Moderna return to normal?
Moderna CEO Stéphane Bancel recently stated in an interview with Swiss newspaper Neue Zuercher Zeitung that life could return to normal in the second half of 2022. But no one knows for sure what a return to normalcy will mean for sales of Moderna's COVID-19 vaccine.
Is Moderna stock going to fall?
Wall Street's answer to that question is that Moderna's share price isn't likely to fall at all. The average analysts' price target for the stock is actually slightly higher than the current share price.
Will Moderna stock fall in 2022?
The stock could fall another 30%, though, if it's clear that Moderna's vaccine sales will slump after 2022.
Is Moderna stock cheap?
At first glance, Moderna actually looks quite cheap. Its shares trade at only a little over 11 times expected earnings.
